Avid Bioservices, Inc. revenue increases to $149.27 million in 2023 from previous year
Key fundamental financials- profit of $560,000
- Revenue of $149.27 million
- earnings per share of $0.01
By USInMinutes
Published - Jun 21, 2023, 06:52 PM ET
Last Updated - Jul 18, 2023, 03:07 PM EDT
| Current Reporting | Revenue | Net Income | Profit/Loss |
|---|---|---|---|
| Apr 2023 | $149.27 million | $560,000 | profit |
| Apr 2022 | $119.60 million | $127.67 million | profit |
| Apr 2021 | $95.87 million | $11.21 million | profit |
Avid Bioservices, Inc. [CDMO] has reported $560,000 profit for the fiscal year ending Apr 30, 2023 while the earnings for the same period were $0.01 per share.
Revenue for the year was $149.27 million with operating income of $3.60 million.
The Tustin, California (CA)-based company operating in the pharmaceutical preparations sector has total shareholders equity of $189.47 million.
Also read:
This is a developing story. Click here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.
Our Offices
10kInfo, Inc.
13555 SE 36th St
Bellevue, WA 9800610kInfo Data Solutions, Pvt Ltd.
Claywork Create
11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
Bengaluru, Karnataka 560076
4.2 12182024
Popular News
